8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (May 3, 2012)

Filed May 3, 2012For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on May 3, 2012, to report its financial results for the first quarter ended March 31, 2012. The key information for investors is contained within the press release furnished as Exhibit 99.1 to this filing. While the 8-K itself is a notification of the release, the press release would detail operational performance, financial condition, and potentially forward-looking statements related to Alnylam's pipeline and strategic progress. Investors should refer to the accompanying press release for specific financial figures, such as revenue, net loss, cash position, and any updates on clinical trial progress or drug development milestones that would impact the company's valuation and future prospects.

Key Highlights

  • 1Alnylam Pharmaceuticals announced its financial results for the quarter ended March 31, 2012, via an 8-K filing.
  • 2The primary purpose of the filing was to furnish a press release detailing these financial results.
  • 3The press release (Exhibit 99.1) is the key document for investors to review for specific financial performance and operational updates.
  • 4The filing does not contain new material agreements or significant corporate events beyond the financial results announcement.
  • 5Information provided in the 8-K and its exhibits is furnished, not filed, meaning it's not subject to the same liabilities under Section 18 of the Exchange Act.
  • 6Investors need to consult the referenced press release for details on revenue, expenses, cash flow, and any pipeline developments.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and furnish Alnylam Pharmaceuticals' financial results for the first quarter ended March 31, 2012, through an accompanying press release.

The detailed financial results and operational updates are contained within the press release dated May 3, 2012, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for specific figures and commentary.

No, the information in this Form 8-K, including the furnished press release, is considered 'furnished' and not 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities of that section unless specifically incorporated by reference into another filing.

This particular 8-K filing is solely focused on reporting the company's financial results for the first quarter of 2012. It does not appear to report on new strategic partnerships or other significant business developments, as those would typically be disclosed in separate 8-K items or other filings.